WallStSmart
NEO

NeoGenomics Inc

NASDAQ: NEO · HEALTHCARE · DIAGNOSTICS & RESEARCH

$9.26
+3.35% today

Updated 2026-04-30

Market cap
$1.17B
P/E ratio
P/S ratio
1.60x
EPS (TTM)
$-0.84
Dividend yield
52W range
$5 – $14
Volume
2.1M

NeoGenomics Inc (NEO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-693782.00$-2.64M$-138306.00$-1.50M$-2.05M$69000.00$-492000.00$2.23M$9.45M$6.39M$21.48M$18.04M$44.79M$23.37M$1.46M$-26.72M$-65.99M$-1.95M$7.02M$5.23M
Capital expenditures$398618.00$516144.00$501781.00$963740.00$916000.00$897000.00$3.65M$2.01M$3.77M$2.21M$7.54M$13.69M$14.31M$20.03M$29.10M$64.14M$30.89M$28.75M$41.06M$27.01M
Depreciation
Stock-based comp$246180.00$372951.00$411000.00$458000.00$798000.00$929000.00$692000.00$3.48M$5.44M$6.44M$6.96M$10.00M$10.21M$22.46M$24.67M$24.63M$33.41M$41.32M
Free cash flow$-1.09M$-3.16M$-640087.00$-2.46M$-2.97M$-828000.00$-4.14M$216000.00$5.68M$4.18M$13.94M$4.35M$30.48M$3.34M$-27.64M$-90.86M$-96.88M$-30.70M$-34.04M$-21.78M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$87.86M$0.00$9.60M
Share repurchases
Debt repayment
Net change in cash$1.53M$-760000.00$2.97M$28.86M$-10.27M$-10.89M$296000.00$-3.01M$163.21M$77.62M$66.19M$-53.65M